Reza Dana, MD
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival (NCT01996826) | Reza Dana, MD | 2014-04-01 |
| Treatment of Corneal Neovascularization With Topical Pazopanib (NCT01257750) | Reza Dana, MD | 2010-11-01 |
| Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival (NCT01072357) | Reza Dana, MD | 2009-12-01 |
| Topical IL-1-Ra for Treatment of Corneal Neovascularization (NCT00915590) | Reza Dana, MD | 2009-04-01 |
| Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) (NCT00681889) | Reza Dana, MD | 2008-04-01 |
| Topical IL-1-Ra for Treatment of Posterior Blepharitis (NCT00681109) | Reza Dana, MD | 2008-01-01 |
Track Reza Dana, MD automatically
Every clearance here is in the API, with alerts when new ones post.